gabapentin has been researched along with carboplatin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fleming, GF | 1 |
| Iżycka, N; Kapoła-Czyż, J; Lorek, J; Magnowska, M; Nowak-Markwitz, E; Romała, A; Spaczyński, M | 1 |
1 review(s) available for gabapentin and carboplatin
| Article | Year |
|---|---|
Second-Line Therapy for Endometrial Cancer: The Need for Better Options.
Topics: Adenocarcinoma; Amines; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Clinical Trials as Topic; Cyclohexanecarboxylic Acids; Endometrial Neoplasms; Estrogen Receptor alpha; Female; Fluorouracil; Gabapentin; gamma-Aminobutyric Acid; Humans; Medical Oncology; Middle Aged; Paclitaxel; Receptors, Progesterone; Rectal Neoplasms; Stroke; TOR Serine-Threonine Kinases; Treatment Outcome | 2015 |
1 other study(ies) available for gabapentin and carboplatin
| Article | Year |
|---|---|
Effectiveness of gabapentin pharmacotherapy in chemotherapy-induced peripheral neuropathy.
Topics: Adult; Amines; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cyclohexanecarboxylic Acids; Female; Gabapentin; gamma-Aminobutyric Acid; Humans; Middle Aged; Ovarian Neoplasms; Paclitaxel; Peripheral Nervous System Diseases | 2018 |